Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 291-793-4 | CAS number: 90480-58-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No skin sensitisation study with Octanoic acid, zinc salt, basic is available, thus the skin sensitisation potential will be addressed with existing data on the moieties liberated upon dissolution zinc and octanoic acid, supported by human data on structurally similar zinc salts of fatty acids.
Octanoic acid, zinc salt, basic is not expected to show signs of dermal sensitisation, since the two moieties zinc and octanoic acid have not shown any skin sensitisation potential in experimental testing. Furthermore, human data on structurally similar zinc salts of fatty acids do not indicate sensitising potential as well.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Octanoic acid, zinc salt, basic
Octanoic acid, zinc salt, basic is not expected to show signs of dermal sensitisation, since the twoassessment entitieszinc and octanoic acid have not shown any skin sensitisation potential in experimental testing. Furthermore, human data on structurally similar zinc salts of fatty acids do not indicate sensitising potential as well. Thus, octanoic acid, zinc salt, basic is not to be classified according to regulation (EC) 1272/2008 as skin sensitising.
Read-across approach and conclusion are in line with the EU risk assessment carried out on the structurally similar substance Fatty acids, C16-18, zinc salts (i.e. zinc stearate) within the framework of EU Existing Chemicals Regulation 793/93 (EU RAR Zinc stearate (CAS# 91051-01-3, CAS# 557-05-1) Part II–Human Health. EUR 21168 EN (http://echa.europa.eu/documents/10162/08799aec-42c5-44e0-9969-baa022c66db1): “Animal data on skin sensitisation are not available for zinc distearate. However, based on the accepted derogation and the fact that zinc oxide is not a skin sensitiser, it is consequently concluded that zinc distearate is not likely to be skin sensitising, and therefore does not need to be classified/labelled. This is supported by the fact that the use of zinc distearate in pharmaceutical and cosmetic products is without reported skin sensitisation effects.”
Further testing is not required.
Please refer to the respective assessment entity section for data on the moieties zinc and octanoic acid. In brief:
Zinc
The skin sensitising potential of zinc oxide (purity 99.69%) was investigated in female Dunkin Hartley guinea pigs in two well-performed maximisation tests, conducted according to Directive 96/54/EC B.6 and OECD guideline 406. Based on the results of a preliminary study, in the main studies experimental animals (10 in each test) were intradermally injected with a 20% concentration and epidermally exposed to a 50% concentration (i. e. the highest practically feasible concentration). Control animals (5 in each test) were similarly treated, but with vehicle (water) alone. Approximately 24 hours before the epidermal induction exposure all animals were treated with 10% SDS. Two weeks after the epidermal application all animals were challenged with a 50% test substance concentration and the vehicle. In the first study, in response to the 50% test substance concentration skin reactions of grade 1 were observed in 4/10 experimental animals 24 hours after the challenge (40% sensitisation rate), while no skin reactions were evident in the controls. In contrast, in the second study no skin reactions were evident in the experimental animals (0% sensitisation rate), while a skin reaction grade 1 was seen in one control animal. The skin reaction observed in one control animal is probably a sign of non specific irritation (Van Huygevoort, 1999b1, 1999b2).
In a third well-performed maximisation test, conducted according to the same guidelines and with the same experimental design, another analytical grade zinc oxide was tested (Zincweiß Pharma A; purity 99.9%). The only difference with the studies described above was the intradermal induction concentration, which was 2% as for Zincweiß Pharma A this was considered the highest concentration that could reproducibly be injected. In this test no skin reactions were evident in both experimental and control animals, hence a 0% sensitisation rate for Zincweiß Pharma A. White staining of the treated skin by the test substance was observed in some animals 24 and 48 hours after challenge (Van Huygevoort, 1999a).
Human data:
In a human patch test performed with 100 selected leg-ulcer patients, 11/100 patients gave an allergic reaction with zinc ointment (60% ZnO and 40% sesame oil). However, 14/81 patients gave a positive response when treated with sesame oil alone. This study does not give any indication for a skin sensitizing potential of zinc oxide in humans (Malten and Kuiper, 1974).
The effect of zinc oxide on contact allergy to colophony was investigated. With 14 patients with earlier history of moderate patch test reactions to colophony (a patch test) with 10% ZnO (2.3 mg Zinc/cm²) with and without colophony was performed. No positive response was observed in the 14 patients when only a 10% solution of zinc oxide was used. The addition of zinc oxide to colophony decreased the allergic reaction induced by colophony (Söderberg et al., 1990).
Octanoic acid
Octanoic acid is a naturally occurring saturated C8- fatty acid, which is present in milk of various mammals and also in coconut oil and palm kernel oil. Based on this, the following endpoint is covered by publicly available data on fatty acids with the same or similar structure.
The non-sensitising properties of fatty acids were demonstrated in a skin sensitisation study in 28 volunteers. “Five 48-hour covered applications of 1% decanoic acid (C10) in petrolatum were made over a 10 day period. The results were negative since none gave positive reactions when challenged 10-14 days after the induction phase with a final 48-hour closed patch test using 1% in petrolatum (IUCLID, 2000a)” (HERA, 2002).
Further, KeratinoSens is one of the validated alternative methods for testing sensitisation in vitro. Octanoic acid and various other substances were used throughout the validation process of this system. The already known non-sensitising properties of octanoic acid determined in in vivo-experiments were proved once again in the KeratinoSens assay (Emter, R. et al.; 2010).
Structurally similar zinc salts of fatty acids
In studies in humans, two eye shadow formulations, each containing 10% Fatty acids, C16-18, zinc salts, were tested in the Schwartz-Peck Prophetic Patch assay and the Draize-Shelanski Repeated Insult Patch Assay. Both tests resulted in “virtually 0 reactions”. One of the formulations was applied twice daily for 28 days to 52 females. No “irritation or sensitisation” was noted when examined up to four weeks after application (CIR, 1982). Also a test on human volunteers twice a day for 28 days treated with a cosmetic formulation (eye shadow product) containing Fatty acids, C26-28, zinc salts, gave no indication on a sensitising activity. Reliable, adequate and relevant animal and human data on slightly soluble zinc oxide indicated no skin sensitising potential.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Octanoic acid, zinc salt, basic is not expected to show signs of dermal sensitisation, since the two moieties zinc and octanoic acid have not shown any skin sensitisation potential in experimental testing. In addition, human data on structural similar zinc salts of fatty acids also do not indicate sensitising potential. Thus, Octanoic acid, zinc salt, basic is not to be classified according to regulation (EC) 1272/2008 and its subsequent amendments as skin sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.